SEARCH

SEARCH BY CITATION

References

  • 1
    Chen G, Gharib TG, Wang H et al . Protein profiles associated with survival in lung adenocarcinoma. Proc Natl Acad Sci USA 2003; 100: 13 53742.
  • 2
    Granville CA, Dennis PA. An overview of lung cancer genomics and proteomics. Am J Respir Cell Mol Biol 2005; 32: 16976.
  • 3
    Xiao T, Ying W, Li L et al . An approach to studying lung cancer-related proteins in human blood. Mol Cell Proteomics 2005; 4: 14806.
  • 4
    Kulpa J, Wojcik E, Reinfuss M et al . Carcinoembryonic antigen, squamous cell carcinoma antigen, CYFRA21-1, and neuro-specific enolase in squamous cell lung cancer patients. Clin Chem 2002; 48: 193137.
  • 5
    Brundage MD, Davies D, Mackillop WJ. Prognostic factors in non-small cell lung cancer: a decade of progress. Chest 2002; 122: 103757.
  • 6
    Yu Y, Chen S, Wang LS et al . Prediction of pancreatic cancer by serum biomarkers using surface-enhanced laser desorption/ionization-based decision tree classification. Oncology 2005; 68: 7986.
  • 7
    Ward DG, Cheng Y, Kontchou GN et al . Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis. Br J Cancer 2006; 94: 28792.
  • 8
    Ward DG, Suggett N, Cheng Y et al . Identification of serum biomarkers for colon cancer by proteomic analysis. Br J Cancer 2006; 94: 1898905.
  • 9
    Adam BL, Qu Y, Davis JW et al . Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res 2002; 62: 360914.
  • 10
    Petricoin EF, Ardekani AM, Hitt BA et al . Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002; 359: 5727.
  • 11
    Chen YD, Zheng S, Yu JK et al . Artificial neural networks analysis of surface-enhanced laser desorption/ionization mass spectra of serum protein pattern distinguishes colorectal cancer from healthy population. Clin Cancer Res 2004; 10: 83805.
  • 12
    Valle RP, Chavany C, Zhukov TA et al . New approaches for biomarker discovery in lung cancer. Expert Rev Mol Diagn 2003; 3: 5567.
  • 13
    Xiao X, Liu D, Tang Y et al . Development of proteomic patterns for detecting lung cancer. Dis Markers 2004; 19: 339.
  • 14
    Power DM, Elias NP, Richardson SJ et al . Evolution of the thyroid hormone-binding protein, transthyretin. Gen Comp Endocrinol 2000; 119: 24155.
  • 15
    Fung ET, Yip TT, Lomas L et al . Classification of cancer types by measuring variants of host response proteins using SELDI serum assays. Int J Cancer 2005; 115: 7839.
  • 16
    Jacobsson B, Collins VP, Grimelius L et al . Transthyretin immunoreactivity in human and porcine liver, choroid plexus, and pancreatic islets. J Histochem Cytochem 1989; 37: 317.
  • 17
    Itoh N, Hanafusa T, Miyagawa J et al . Transthyretin (prealbumin) in the pancreas and sera of newly diagnosed type I (insulin-dependent) diabetic patients. J Clin Endocrinol Metab 1992; 74: 13727.
  • 18
    Thomas JGL, Jeffrey M, Victoria M et al . Transthyretin (prealbumin) immunoreactivity in renal cell carcinoma and other neoplasms. Int J Surg Pathol 1996; 4: 17.
  • 19
    Menard C, Johann D, Lowenthal M et al . Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysis. Cancer Res 2006; 66: 184450.
  • 20
    Lowenthal MS, Mehta AI, Frogale K et al . Analysis of albumin-associated peptides and proteins from ovarian cancer patients. Clin Chem 2005; 51: 193345.
  • 21
    Liotta LA, Petricoin EF. Serum peptidome for cancer detection: spinning biologic trash into diagnostic gold. J Clin Invest 2006; 116: 2630.
  • 22
    Geho DH, Liotta LA, Petricoin EF et al . The amplified peptidome: the new treasure chest of candidate biomarkers. Curr Opin Chem Biol 2006; 10: 505.
  • 23
    Raghu P, Sivakumar B. Interactions amongst plasma retinol-binding protein, transthyretin and their ligands. implications in vitamin A homeostasis and transthyretin amyloidosis. Biochim Biophys Acta 2004; 1703: 19.
  • 24
    Imanishi T. Clinical and experimental studies on the profiles of serum proteins in acute hepatic injury. Gastroenterol Jpn 1981; 16: 493505.
  • 25
    Marten NW, Sladek FM, Straus DS. Effect of dietary protein restriction on liver transcription factors. Biochem J 1996; 317: 36170.
  • 26
    Ritchie RF, Palomaki GE, Neveux LM et al . Reference distributions for the negative acute-phase serum proteins, albumin, transferrin and transthyretin: a practical, simple and clinically relevant approach in a large cohort. Clin Lab Anal 1999; 13: 2739.
  • 27
    Kozak KR, Su F, Whitelegge JP et al . Characterization of serum biomarkers for detection of early stage ovarian cancer. Proteomics 2005; 5: 458996.
  • 28
    Xiao X, Zhao X, Liu J et al . Discovery of laryngeal carcinoma by serum proteomic pattern analysis. Sci Chin 2004; 47: 21923.
  • 29
    Bagga D, Wang L, Farias-Eisner R et al . Differential effects of prostaglandin derived from -6 and -3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc Natl Acad Sci USA 2003; 100: 17516.
  • 30
    Altland K, Winter P. Polyacrylamide gel electrophoresis followed by sodium dodecyl sulfate gradient polyacrylamide gel electrophoresis for the study of the dimer to monomer transition of human transthyretin. Electrophoresis 2003; 24: 226571.
  • 31
    Amareth L, Tatiana P, Mark EM et al . Identification of S-sulfonation and S-thiolation of a novel transthyretin Phe33Cys variant from a patient diagnosed with familial transthyretin amyloidosis. Protein Sci 2003; 12: 177585.
  • 32
    Ferlini A, Fini S, Salvi F et al . Molecular strategies in genetic diagnosis of transthyretin-related hereditory amyloidosis. FASEB J 1992; 6: 28646.
  • 33
    Gericke B, Raila J, Sehouli J et al . Microheterogeneity of transthyretin in serum and ascitic fluid of ovarian cancer patients. BMC Cancer 2005; 5: 133.
  • 34
    Lim A, Sengupta S, McComb ME et al . In vitro and in vivo interactions of homocysteine with human plasma transthyretin. J Biol Chem 2003; 278: 49 70713.
  • 35
    Bergen HR, Zeldenrust SR, Butz ML et al . Identification of transthyretin variants by sequential proteomic and genomic analysis. Clin Chem 2004; 50: 154452.
  • 36
    Liu DH, Wang XM, Zhang LJ et al . Serum amyloid A protein: a potential biomarker correlated with clinical stage of lung cancer. Biomed Environ Sci 2007; 20: 3340.
  • 37
    Dai SW, Wang XM, Liu LY et al . Discovery and identification of serum amyloid A protein elevated in lung cancer serum. Sci China 2007; 50: 30511.
  • 38
    Ingenbleek Y, Young V. Transthyretin (prealbumin) in health and disease: nutritional implications. Annu Rev Nutr 1994; 14: 495533.
  • 39
    Schreiber G. The evolutionary and integrative roles of transthyretin in thyroid hormone homeostasis. J Endocrinol 2002; 175: 6173.
  • 40
    Madri JA. The evolving roles of cell surface proteases in health and disease: implications for development, adaptive, inflammatory, and neoplastic processes. Curr Top Dev Biol 2003; 54: 391410.
  • 41
    Zucker S, Hymowitz M, Conner C et al . Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental application. Ann NY Acad Sci 1999; 878: 21227.
  • 42
    Bank U, Kurger S, Langner J et al . Review: peptidases and peptidase inhibitors in the pathogenesis of diseases, disturbances in the ubiquitin-mediated proteolytic system, protease-antiprotease imbalance in inflammatory reactions, role of cathepsins in tumour progression. Adv Exp Med Biol 2000; 477: 34978.
  • 43
    Blasi F. Proteolysis, cell adhesion, chemotaxis, and invasiveness are regulated by the u-PA-U-PAR-PAI-I system. Thromb Haemost 1999; 82: 298304.
  • 44
    Zhang Z, Bast RC, Yu Y Jr et al . Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res 2004; 64: 588290.